This topic contains a solution. Click here to go to the answer

Author Question: Identical twins will have identical fingerprints. Indicate whether the statement is true or ... (Read 70 times)

Marty

  • Hero Member
  • *****
  • Posts: 553
Identical twins will have identical fingerprints.
 
  Indicate whether the statement is true or false

Question 2

If intraperitoneal bleeding occurs, the signs of rebound, guarding, and rigidity may not be manifested as well in a pregnant female because of:
 
  A) the loss of uterine tone and the development of the fetus.
  B) the compression of the inferior vena cava, cutting off preload to the heart.
  C) hypertension and the associated incidence of abruptio placenta.
  D) gradual stretching of the abdominal wall, along with hormonal changes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

princessflame2016

  • Sr. Member
  • ****
  • Posts: 298
Answer to Question 1

F

Answer to Question 2

D




Marty

  • Member
  • Posts: 553
Reply 2 on: Jul 3, 2018
:D TYSM


LVPMS

  • Member
  • Posts: 323
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library